
A photograph of the handheld probe. The motor, translation stage, ultrasonic transducer, and optical fibers are all incorporated in this handheld probe for easy operation. Image courtesy of Yong Zhou.
A new hand-held device that uses lasers and sound waves may change the way doctors treat and diagnose melanoma, according to a team of researchers from Washington University in St. Louis.
The instrument, described in a paper published today in The Optical Society’s (OSA) journal Optics Letters, is the first that can be used directly on a patient and accurately measure how deep a melanoma tumor extends into the skin, providing valuable information for treatment, diagnosis or prognosis.
Melanoma is the fifth most common cancer type in the United States, and incidence rates are rising faster than those of any other cancer. It’s also the deadliest form of skin cancer, causing more than 75 percent of skin-cancer deaths.
The thicker the melanoma tumor, the more likely it will spread and the deadlier it becomes, says dermatologist Lynn Cornelius, one of the study’s coauthors. Being able to measure the depth of the tumor in vivo enables doctors to determine prognoses more accurately—potentially at the time of initial evaluation—and plan treatments and surgeries accordingly.
The problem is that current methods can’t directly measure a patient’s tumor very well. Because skin scatters light, high-resolution optical techniques don’t reach deep enough. “None are really sufficient to provide the two to four millimeter penetration that’s at least required for melanoma diagnosis, prognosis or surgical planning,” says engineer Lihong Wang, another coauthor on the Optics Letters paper.
Researchers have tried other methods, but they aren’t much better. High-frequency ultrasound doesn’t have enough image contrast, and magnetic resonance imaging and positron emission tomography have insufficient resolution and require expensive and bulky instruments.
“Any type of tissue diagnosis at this point in time requires taking tissue out of the person and processing it and looking at it under the microscope,” Cornelius says.
But because taking a biopsy often only involves the removal of a part of a tumor—when it’s in a cosmetically sensitive area, for instance—provisional measurements of the tumor depth are not always reliable. If, at the time of excision, the surgeon finds that the tumor goes deeper than initially thought, the patient may need yet another surgery.
Recently, researchers including Wang have applied an approach called photoacoustic microscopy, which can accurately measure melanoma tumors directly on a patient’s skin—thus allowing doctors to avoid uncertainty in some circumstances.
The technique relies on the photoacoustic effect, in which light is converted into vibrations. In the case of the new device, a laser beam shines into the skin at the site of a tumor. Melanin, the skin pigment that’s also in tumors, absorbs the light, whose energy is transferred into high-frequency acoustic waves. Unlike light, acoustic waves don’t scatter as much when traveling through skin. Tumor cells will produce more melanin than the surrounding healthy skin cells, and as a result, the acoustic waves can be used to map the entire tumor with high resolution. The device has a detector that can then turn the acoustic signal into a three-dimensional image on a screen.
Read more . . .
The Latest on: Melanoma
[google_news title=”” keyword=”Melanoma” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Melanoma
- ‘Tips for Tad’ fundraiser to fight melanoma set for June 17on June 7, 2023 at 6:33 pm
The foundation was established by Tad’s parents as a memorial to honor him after losing a two-year battle with stage 4 melanoma brain cancer. This marks 11 years of 'Tips for Tad' events raising money ...
- Arizona's melanoma rates are about 40% higher than U.S. averageon June 7, 2023 at 6:20 am
By the numbers: Arizona's estimated rate of annual melanoma cases per 100,000 residents was 42.3 in 2022, compared with the national rate of 29.9, per the American Cancer Society. Why it matters: ...
- DermTech stock surges after it announces contract with Hawaii Blues plan for melanoma teston June 7, 2023 at 6:06 am
Molecular diagnostic company DermTech (DMTK) shares jumps 7.6% premarket on Wednesday after it signs a contract with a Blues plan in Hawaii ...
- Melanoma awareness: What to know and what to look foron June 6, 2023 at 11:27 am
As the weather gets warmer and people spend more time outside, it's important to protect yourself against skin cancer.
- Moderna (MRNA), Merck's Cancer Jab Delays Melanoma Spreadingon June 6, 2023 at 7:42 am
Moderna MRNA and partner Merck MRK announced new results from the phase IIb KEYNOTE-942 study, which evaluated their personalized cancer vaccine (“PCV”) candidate, mRNA-4157/V940, in melanoma ...
- Melanoma vaccine trial appears to reduce skin cancer recurrenceon June 6, 2023 at 6:30 am
Drug companies Moderna and Merck have released encouraging results from a vaccine trial that shows promise in the battle against Stage 3 and Stage 4 melanoma, the most serious type of skin cancer. NBC ...
- Moderna-Merck cancer jab blunts melanoma spread when dosed with Keytrudaon June 5, 2023 at 11:38 am
Moderna and Merck announced Monday that an individualized neoantigen therapy in combination with PD-1 therapy Keytruda blunted the risk of cancer metastasis or death by 65% among high-risk melanoma ...
- Month long treatment with Imiquimod may induce regression of lentigo maligna melanomaon June 5, 2023 at 7:30 am
A new study by Marie Daude and team showed that after a month of therapy, imiquimod lowers the lentigo maligna surface, without increasing the risk of intralesional excision, and with ...
- Moderna/ Merck cancer shot with Keytruda cut melanoma spreadon June 5, 2023 at 6:26 am
Moderna (MRNA) and Merck (MRK) said Monday that their cancer shot mRNA-4157 (V940), with Keytruda cut the risk cancer metastasis or death in melanoma. Read more here.
- Melanoma Survival Rate Boosted by Memory Cellson June 5, 2023 at 5:00 am
High levels of memory killer cells in cancer tissue correlate with a better survival rate in people with melanoma.
via Bing News